Category Archives: Top Market News

Oppenheimer Reiterates a Hold Rating on MiX Telematics

Oppenheimer analyst Brian Schwartz reiterated a Hold rating on MiX Telematics (NYSE: MIXT) today. The company’s shares opened today at $6.66. Schwartz wrote: “MiX Telematics finished FY:2017 with a good quarter and showed F4Q results beating consensus estimates. Total subscribers

ContraFect Gets a Hold Rating from Maxim Group

In a report released today, Jason McCarthy from Maxim Group reiterated a Hold rating on ContraFect (NASDAQ: CFRX). The company’s shares opened today at $1.40, close to its 52-week low of $1.20. McCarthy said: “ContraFect announced that the P2 study

Arch Therapeutics Inc Receives a Buy from Roth Capital

Roth Capital analyst Michael Higgins reiterated a Buy rating on Arch Therapeutics Inc (Other OTC: ARTH) today and set a price target of $3. The company’s shares opened today at $0.50. Higgins wrote: “We met this week with Arch’s CEO

Analysts Conflicted on These Technology Names: Guidance Software (NASDAQ: GUID), Glu Mobile (NASDAQ: GLUU) and JA Solar (NASDAQ: JASO)

Analysts have been eager to weigh in on the Technology sector with new ratings on Guidance Software (NASDAQ: GUID), Glu Mobile (NASDAQ: GLUU) and JA Solar (NASDAQ: JASO). Guidance Software (NASDAQ: GUID) Roth Capital analyst Brian Alger reiterated a Buy

Maxim Group Reaffirms Their Buy Rating on GW Pharma

In a report released today, Gabrielle Zhou from Maxim Group reiterated a Buy rating on GW Pharma (NASDAQ: GWPH), with a price target of $135. The company’s shares opened today at $110.50. Zhou said: “GW pharmaceuticals announced publication of data

BMO Capital Keeps Their Hold Rating on HP Inc

In a report released yesterday, Tim Long from BMO Capital reiterated a Hold rating on HP Inc (NYSE: HPQ), with a price target of $20. The company’s shares opened today at $19.57, close to its 52-week high of $19.58. According